Trials / Completed
CompletedNCT04987164
Incidence of Cystitis in Women Consuming a Mixture of Cranberry, Cinnamon, Probiotics
Observational Study Evaluating the Number of Symptomatic Cystitis-like Episodes and Urinary Comfort of Women Consuming Cranberry, Cinnamon and Probiotic Strain Extracts
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (actual)
- Sponsor
- CEN Biotech · Industry
- Sex
- Female
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Cranberries are traditionally used for urinary comfort and prevention of urinary disorders of bacterial origin and despite an EFSA opinion invalidating the clinical efficacy of cranberries, its mechanism of action has been several times proposed by the scientific community: it would act by inhibiting the synthesis of P-fimbriae leading to a complete disappearance of these adhesins, and to bacterial-type deformation by lengthening of the cell body. Cinnamon and microbiotic strains could enhance this synergy. This study aims to evaluate the effectiveness of a food supplement based on cranberry, cinnamon and microbiotic strains (Feminabiane CBU) on the symptoms of cystitis, urinary discomfort and the number of cystitis reported by women.
Detailed description
Women who use or not the cranberry, cinnamon, and microbiotic blend are encouraged to complete a 6-month diary in which they report any urinary tract disorders they encounter.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Feminabiane CBU | EXTRACTS OF CRANBERRY, CINNAMON AND MICROBIOTIC STRAINS |
Timeline
- Start date
- 2021-11-18
- Primary completion
- 2022-08-04
- Completion
- 2022-08-04
- First posted
- 2021-08-03
- Last updated
- 2023-03-02
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT04987164. Inclusion in this directory is not an endorsement.